Clinical Genetic Test
offered by
GTR Test Accession:
Help
GTR000506215.8
Last updated in GTR:
2023-06-14
View version history
GTR000506215.8,
last updated:
2023-06-14
GTR000506215.7,
last updated:
2022-07-12
GTR000506215.6,
last updated:
2020-07-15
GTR000506215.5,
last updated:
2019-07-26
GTR000506215.4,
last updated:
2018-07-25
GTR000506215.3,
last updated:
2017-07-25
GTR000506215.2,
last updated:
2014-08-18
GTR000506215.1,
registered in GTR:
2014-08-05
Last annual review date for the lab: 2024-06-28
LinkOut
At a Glance
Test purpose:
Help
Diagnosis
Conditions (38):
Help
Analytes (54):
Help
2-Oxoisocaproic acid;
2-Oxoisovalerate;
2-ethyl-3-hydroxypropionic acid;
2-hydroxy-3-methylvaleric acid;
2-hydroxyadipic acid
more...
Methods (1):
Help
Biochemical Genetics - Analyte: Gas chromatography–mass spectrometry (GC-MS)
Target population: Help
Not provided
Clinical validity:
Help
Not provided
Clinical utility:
Help
Not provided
Ordering Information
Offered by:
Help
Specimen Source:
Help
Test Order Code:
Help
35819
View other test codes
View other test codes
Lab contact:
Help
Biochemical Genetic Department, ,
949-728-4423 or 949-728-4817
949-728-4423 or 949-728-4817
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
Informed consent required:
Help
Based on applicable state law
Test strategy:
Help
http://www.questdiagnostics.com/
Pre-test genetic counseling required:
Help
No
Post-test genetic counseling required:
Help
No
Recommended fields not provided:
Test development
Conditions
Help
Total conditions: 38
Condition/Phenotype | Identifier |
---|
Test Targets
Analytes
Help
Total analytes: 54
Analyte | Associated Condition |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument *
Analyte
Gas chromatography–mass spectrometry (GC-MS)
* Instrument: Not provided
Clinical Information
Test purpose:
Help
Diagnosis
Recommended fields not provided:
Clinical validity,
Clinical utility,
Target population,
What is the protocol for interpreting a variation as a VUS?,
Are family members with defined clinical status recruited to assess significance of VUS without charge?,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
LOQ=1-2 mmol/mol crt ; +-30% accuracy
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
European Research Network for the Evaluation and Improvement of Screening Diagnosis and Treatment of Inherited Metabolic Disorders - External Quality Assessment Schemes, ERNDIM EQAS
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
European Research Network for the Evaluation and Improvement of Screening Diagnosis and Treatment of Inherited Metabolic Disorders - External Quality Assessment Schemes, ERNDIM EQAS
Recommended fields not provided:
Test Confirmation,
Assay limitations,
Description of internal test validation method,
Citations for Analytical validity,
Description of PT method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Not provided
Additional Information
Clinical resources:
Practice guidelines:
Consumer resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.